[HIGHLIGHTS] China's approval of the first COVID-19 neutralizing antibody drug sparks heated debate in the industry on how to price and distribute it 2021-12-08T20:11:03.981Z Read the full translated version in English Read the full version from chinanews May on the same topic in other locals All business stories on 2021-12-08